Evidence map›Paper›PMID 31679249›Full record

ReviewCritical reviews in immunology2019

The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis.

Meihua Zhang, Weiwei Liang, Wanghua Gong, Teizo Yoshimura, Keqiang Chen, Ji Ming Wang

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Quorum SensingFrontiers in molecular biosciences · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Meihua ZhangKey Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Jinan, China; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Weiwei LiangCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland; Department of Immunology, School of Basic Medical Sciences and Key Laboratory of Medical Immunology of Ministry of Health, Peking University, Health Science Center, Beijing, China.
Wanghua GongBasic Research Program, Leidos Biomedical Research, Inc., Frederick, Maryland.
Teizo YoshimuraDepartment of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Keqiang ChenCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
Ji Ming WangCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
National Cancer Institute · USLeidos (United States) · USNational Health and Family Planning Commission · CNOkayama University · JPPeking University · CN

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

Mouse cathelin-related antimicrobial peptide (CRAMP) and its homologue human cathelicidin (LL-37) play active roles in innate immune responses, angiogenesis, and wound healing. In addition, LL-37/CRAMP fends off microbes and protects against infections in the colon, where the epithelium is exposed to myriad of enteric pathogens. It is increasingly recognized that LL-37/CRAMP maintains colon mucosal barrier integrity, shapes the composition of microbiota, and protects the host from tumorigenesis. In this review, we discuss the importance of LL-37/CRAMP in the homeostasis of the host, with novel findings derived from mice deficient in CRAMP that support the proposition for this natural antimicrobial peptide and an immune modulator as a drug lead for therapeutic development.

Indexed as

AnimalsAnti-Inflammatory AgentsAntimicrobial Cationic PeptidesCarcinogenesisCathelicidinsColonColonic NeoplasmsGastrointestinal MicrobiomeHomeostasisHumansImmunity, MucosalIntestinal MucosaMiceMice, KnockoutAnti-Inflammatory AgentsAntimicrobial Cationic PeptidesCathelicidins

Identifiers

PMID31679249
PMCPMC11000334
OpenAlexW2960962903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.